Quinine Global Market Report 2025

The quinine market size has grown strongly in recent years. It will grow from $2.25 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The expansion in previous years was driven by rising malaria cases in tropical zones, increased reliance on conventional antimalarial treatments, enhanced botanical research along colonial trade paths, greater health consciousness in developing nations, and heightened interest in herbal medicines.

The quinine market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 9%. This projected growth will be fueled by growing resistance to synthetic malaria medications, rising acceptance of quinine in homeopathy and alternative treatments, increasing demand for economical malaria remedies, growing traction for traditional medicine practices, and heightened awareness of natural health solutions. Notable trends anticipated in this period include advancements in synthetic substitutes, progress in drug delivery techniques, updates in malaria care strategies, inclusion of quinine in combination drug therapies, and development of formulations that exclude quinine.

The increasing prevalence of malaria is anticipated to drive the growth of the quinine market in the coming years. Malaria, an infectious disease caused by Plasmodium parasites, is transmitted to humans through the bites of infected female Anopheles mosquitoes. The rise in malaria cases is linked to global temperature increases, which expand the habitat range and breeding season of these mosquitoes. Quinine, a powerful antimalarial drug, combats malaria by disrupting the parasite’s ability to digest hemoglobin in red blood cells, thereby hindering its growth and survival. For example, in April 2024, the UK Health Security Agency reported 2,004 confirmed malaria cases in England in 2023, an increase from 1,369 in 2022. This surge in malaria cases is contributing to the growing demand for quinine.

Companies operating in the quinine market are focusing on developing advanced methods for synthesizing quinine and its derivatives to streamline production processes. These innovations aim to minimize time, reduce waste, and cut costs while improving the overall efficiency of chemical synthesis. The laboratory-based synthesis of quinine sulfate mimics its natural extraction from the bark of cinchona trees, allowing for large-scale production used in malaria treatment. For instance, in December 2022, researchers at Tohoku University in Japan achieved a highly efficient enantioselective synthesis of quinine. Their work introduced a one-pot synthesis method using organocatalysts, reducing the number of procedural steps. This innovation significantly lowers chemical waste, shortens production time, and potentially reduces costs, enhancing the development of new drugs and improving overall synthesis efficiency.

In June 2023, AlphaTalents Africa, an investment company based in Africa, acquired a controlling interest in Pharmakina for an undisclosed sum. The acquisition aims to enhance local production of quinine-based drugs, support local communities, and promote sustainable development in the Democratic Republic of the Congo. Pharmakina SA is a pharmaceutical company located in Africa that specializes in manufacturing quinine.

Major players in the quinine market are Teva Pharmaceutical Industries Ltd., Schweppes Australia Proprietary Limited, The United States Pharmacopeial Convention Inc., Chempro Pharma Private Limited, Taj Pharmaceuticals Ltd., Swiss Parenterals Private Limited, Leocorno Enterprises Private Limited, Healthy Inc., Jai Radhe Sales, Adooq Bioscience LLC, Akhil Healthcare Pvt Ltd., Van Wankum Ingredients B.V., Shreeji Pharma International, Prism Industries Private Limited, Lavina Pharmaceuticals Pvt Ltd., A. B. Enterprises, Spark Lifesciences Private Limited, Sihauli Chemicals Private Limited, Shanghai Nianxing Industrial Co. Ltd., and Sakhiya Pharma Chem.

North America was the largest region in the quinine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in quinine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the quinine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Quinine is a naturally occurring compound sourced from the bark of the cinchona tree and has been traditionally employed in the treatment of malaria. Its mechanism of action involves disrupting the growth and reproduction of the malaria parasite within red blood cells. Besides its pharmaceutical application, quinine is also an ingredient in tonic water, contributing to its signature bitter flavor. Although effective, quinine is associated with potential side effects and has often been replaced by newer antimalarial medications.

The primary products derived from quinine include quinine sulphate, quinine hydrochloride, quinine gluconate, and quinine bisulphate. Quinine sulfate, extracted from the cinchona tree, is predominantly used to treat malaria and, in some cases, nocturnal leg cramps. It is available in various forms of administration such as oral, intramuscular, intravenous, and others. Its range of applications covers malaria treatment, alleviation of nocturnal leg cramps, muscle pain, and restless leg syndrome. The key end users include hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.

The quinine market research report is one of a series of new reports that provides quinine market statistics, including the quinine industry's global market size, regional shares, competitors with the quinine market share, detailed quinine market segments, market trends and opportunities, and any further data you may need to thrive in the quinine market. This quinine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The quinine market consists of sales of products including topical ointments, bisulfate capsules, tonic water, and nutraceuticals. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.